The COVID-19 pandemic has shown the devastating consequences of emerging infectious diseases that can spread across borders and affect human and animal health. Many of these diseases are caused by respiratory viruses, such as influenza and coronaviruses, which have the potential to evolve, adapt, and spill over from animal reservoirs to humans. To prevent and control future pandemics, there is a need for rapid, reliable, and cost-effective diagnostic and prognostic tools that can provide timely and accurate information to support decision-making and public trust.
The PAIR project aims to address this challenge by developing and validating two innovative and complementary tools:
• PANPOC: A point-of-care (POC) instrument for rapidly detecting respiratory RNA viruses with pandemic potential in human, animal and environmental samples. PANPOC will be able to test for human and animal influenza A (InfA, AIV and SIV), influenza B and beta-CoV (SARS-CoV-2 variants and emerging beta-coronaviruses), referred to as the Target Viruses.
• PANRISK: A prognostic platform based on artificial intelligence/machine learning (AI/ML) models that can predict the risk of animal pathogen spillover that can infect humans and spatial-temporal outbreaks of zoonoses. PANRISK will use genomic and epidemiological data from public databases and partners' proprietary results to assess pandemic risk based on spatial occurrence (geographical mapping), temporal occurrence patterns, and temporal evolution of viruses (genetic surveillance, bioinformatics analysis).
The tools are designed to meet the comprehensive requirements for a European One Health genomic-informed surveillance and outbreak response model, following the FAIR principles (Findable, Accessible, Interoperable, Reusable) for data management. The tools will be implemented and validated by veterinary and clinical end-users in five Target Countries (DK, FR, LV, IT and ES), and guidelines for EU-wide implementation will be prepared. The project will also involve social sciences and humanities experts to ensure the tools' ethical, legal and social aspects are considered and to foster public engagement and trust. The role of SSH in the project is to provide ethical guidance, legal analysis, stakeholder consultation, social impact assessment, and communication and dissemination strategies.
The main objectives of the project are:
• Development and analytical validation of a low-cost point-of-care system (PANPOC) for detection of the Target Viruses.
• Validation of the PANPOC in vitro diagnostic device for veterinary and clinical use (One Health approach).
• Development of AI/ML-based models to predict the risk of animal pathogen spillover that can infect humans and spatial-temporal outbreaks of zoonoses.
• Development of the PANRISK platform that combines the two prediction models.
• Implementation and validation of PANPOC by clinical end-users in primary and secondary care.
• Implementation and validation of PANRISK by health and veterinary authorities advisory bodies.
• Dissemination, exploitation and communication of the project's critical exploitable results.